Quantcast

Latest Dabigatran Stories

2014-06-20 08:23:38

RIDGEFIELD, Conn., June 20, 2014 /PRNewswire/ -- Boehringer Ingelheim announced today the initiation of a new international study of Pradaxa® (dabigatran etexilate mesylate). The RE-CIRCUIT(TM) trial (Randomized Evaluation of dabigatran etexilate Compared to warfarIn in pulmonaRy vein ablation: assessment of different peri-proCedUral antIcoagulation sTrategies) will evaluate uninterrupted treatment with PRADAXA, compared to warfarin, in patients with paroxysmal or persistent non-valvular...

2014-06-19 23:17:50

Boehringer Ingelheim GmbH, a German pharmaceutical company, recently announced a settlement for approximately 4,000 claims related to injuries and deaths caused by the blood thinner Pradaxa. PHOENIX, AZ (PRWEB) June 19, 2014 The Arizona personal injury firm Phillips Law Group is investigating claims against Boehringer Ingelheim GmbH, the pharmaceutical company who makes the blood thinner Pradaxa. On May 28, a Bloomberg report announced that Boehringer had agreed to settle approximately...

2014-06-19 23:17:47

German drugmaker Boehringer Ingelheim has offered to settle almost 4,000 Pradaxa lawsuits in the United States. The Pradaxa blood thinner is alleged to have cause injuries and fatalities. WINSTON-SALEM, NC (PRWEB) June 19, 2014 Mike Lewis Attorneys, a product liability firm in Tennessee, is reviewing and investigating the impact of Boehringer Ingelheim’s $650 million settlement offer. If successful, the offer would settle more than 4,000 pending Pradaxa claims in the United States. In...

2014-06-19 23:17:43

German pharmaceutical company Boehringer Ingelheim GmbH has agreed to settle nearly 4,000 claims against the drug company for injuries and deaths caused by the blood thinner Pradaxa. MCALESTER, OK (PRWEB) June 19, 2014 The Edwards Law Firm, an Oklahoma pharmaceutical litigation firm, continues to investigate and pursue claims regarding Pradaxa, a blood thinner manufactured by Boehringer Ingelheim GmbH. A Bloomberg report on May 28 announced that Boehringer had agreed to pay $650 million...

2014-06-13 23:07:06

As Flood Law Group continues to investigate Pradaxa lawsuits, the company Boehringer Ingelheim has just paid $650 million to settle thousands of lawsuits against the drug company, according to a May 28, 2014 NY Times article. Washington, D.C. (PRWEB) June 13, 2014 Flood Law Group is pleased with the outcome of the settlement of thousands of lawsuits against the drug manufacturer Boehringer Ingelheim for alleged injuries due to the drug Pradaxa, according to a May 28, 2014 NY Times...

2014-06-10 23:13:15

The Long Island, New York law firm of Rudolph F. X. Migliore, P. C. has announced the makers of the drug called Pradaxa have agreed to pay out 650 million to resolve most of the 4,000 cases filed in state and federal courts. (PRWEB) June 10, 2014 The New York Times states, “Pradaxa, which was approved in 2010, was the first in a new group of blood thinners intended to replace an older treatment, warfarin, which required patients to submit to frequent blood tests and adhere to a strict...

2014-06-10 12:29:47

Additional Novel Oral Anticoagulants are Expected to Gain Approval in China for AF and VTE in the Next Three to Four Years, According to Findings from Decision Resources Group BURLINGTON, Mass., June 10, 2014 /PRNewswire/ -- Decision Resources Group finds that the high cost of therapy remains a significant barrier for uptake of novel oral anticoagulants (NOACs) in the Chinese market. Warfarin, the mainstay of anticoagulation treatment, is listed in the national essential drugs list and is...

2014-06-05 23:01:35

A recent settlement announcement involving Pradaxa has been announced by the manufacture, Boehringer Ingelheim. Toledo, Ohio (PRWEB) June 05, 2014 Boehringer Ingelheim, the manufacturing company of the blood thinning drug Pradaxa, announced in May 2014 a $650 million settlement deal this week to settle approximately 4,000 state and federal lawsuits. Reported by TIME May 2014, Pradaxa was approved by the US Food and Drug Administration (FDA) in October 2010, Pradaxa is formulated for use...

2014-06-03 23:14:55

German pharmaceutical company Boehringer Ingelheim GmbH has agreed to settle thousands of claims against the drug manufacturer for injuries and deaths caused by the blood thinner Pradaxa. Columbus, Ohio (PRWEB) June 03, 2014 O’Connor, Acciani & Levy, an Ohio pharmaceutical litigation firm, continue to investigate claims regarding Pradaxa, a blood thinner manufactured by German pharmaceutical company Boehringer Ingelheim GmbH. According to a Bloomberg report published on May 28,...

2014-05-31 23:04:13

Greg Coleman Law reviews the impact of Boehringer’s settlement offer and the drugmaker’s motivations in light of the more than 4,000 pending Pradaxa lawsuits in U.S. courts. Knoxville, TN (PRWEB) May 31, 2014 Greg Coleman Law, a Tennessee defective drug litigation law firm, continues to express concerns about the proposed Pradaxa litigation settlement announced by Boehringer Ingelheim GmbH on May 28, 2014. The firm continues to review and investigate claims that the blood thinner...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.